“We are ready.For the past week, Sanofi has been preparing for the global rush for chloroquine and hydroxychloroquine. Marketed since the war, its drug, Plaquenil (hydroxychloroquine), prescribed for malaria, lupus and rheumatoid disease, is experiencing a new youth. It is one of the drugs tested in the European Discovery clinical trial. “We have 350,000 boxes in stock, which correspond to around 350,000 patientsExplains Olivier Bogillot, president of Sanofi France.
The laboratory is preparing “activelyTo meet demand if the results are conclusive. Sanofi has said it is ready to deliver millions of doses per month. Since last Saturday, it has started delivering priority French hospitals (Grand Est, Hauts-de-France, Île-de-France, Rhône-Alpes) which can now administer it to the most severe patients.
The first French laboratory, which remains very discreet about its capabilities